Bioscience Company To Sell Cancer-Targeting Cannabinoid Intellectual Property

Enveric Biosciences To Divest Cancer-Targeting Cannabinoid-Related Intellectual Property: A Strategic Shift Towards Mental Health Disorders.

The information contained in this article is accurate and factual to the best of the author's knowledge. The author does not hold any position in Enveric Biosciences and this article does not constitute financial advice. Always do your own research and consult with a professional before making financial decisions.

Enveric Biosciences, a dedicated biotech…